Can a simple screening help cancer patients get mental health support?
NCT ID NCT07117461
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a program that screens cancer patients for emotional distress and refers them to mental health services if needed. It involves 50 English- or Spanish-speaking adults with new solid tumor cancers at Jamaica Hospital Medical Center. The goal is to see if such a program can work in busy safety net hospitals that serve diverse, underserved communities.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- NCCN Distress Thermometer (a simple distress scale)
- What this could lead to
- If successful, this program could help more cancer patients get the mental health support they need, especially those from underserved communities.
- What could go wrong
- This is a small pilot study with only 50 participants, so results may not apply to all cancer patients. It focuses on feasibility, not on proving that the program improves health outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Medisys Health Network (Data Collection Only)
RECRUITINGRichmond Hill, New York, 11418, United States
-
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
RECRUITINGNew York, New York, 10065, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI platform aims to unlock Real-World cancer data on a massive scale
- Can a genetic trait stop chemotherapy from working? a trial aims to fix that
- AI could outshine standard tumor measurements to predict survival
- New drug aims to fight skin cancer in transplant patients
- New imaging agent aims to light up hidden tumors
- New cocktail of old drugs takes on advanced cancers